Partner Content Partner Content Tom Parke to lead a workshop on the new FDA draft guidance during Adaptive Designs in Clinical Trials 2019
News FDA announces further plans to hasten digital health R&D The FDA has announced further details about its plans to hasten development of digital health products and tools.
News Sandoz axes filing of US Rituxan biosimilar Sandoz has abandoned plans to get a cheaper biosimilar of Swiss rival Roche’s cancer drug Rituxan (rituximab) approved in the US.
Views & Analysis Digital health round-up - government and Sandoz recognise tr... Richard Staines presents his weekly round-up of the latest digital health headlines
News New US legislation aims to expedite development of non-opioi... The US Senate looks set to pass a set of laws designed to tackle the country’s opioid crisis, encouraging research into non-addictive painkillers, as well as preventing opioids entering the
News FDA approves Teva's higher-dose opioid dependence therapy Cassipa is higher-dose version of Indivior's Suboxone
News J&J's oral IL-23 drug backed for psoriasis in EU J&J's oral psoriasis drug Icotyde heads up the list of new therapies recommended for EU approval at the CHMP's July meeting.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
